Fluorescent proteins (FPs) are invaluable tools for biomedical research. Useful FPs have desirable fluorescence properties such as brightness and photostability, but a limitation is that many orange, red, and far-red FPs are cytotoxic when expressed in the cytosol. This cytotoxicity stems from aggregation. To reduce aggregation, we engineered the surface of DsRed-Express to generate DsRed-Express2, a highly soluble tetrameric FP that is noncytotoxic in bacterial and mammalian cells. Directed evolution of DsRedExpress2 yielded the color variants E2-Orange, E2-Red/Green, and E2-Crimson. These variants can be used to label whole cells for single-and multi-color experiments employing microscopy or flow cytometry. Methods are described for reducing the higher-order aggregation of oligomeric FPs and for analyzing FP cytotoxicity in Escherichia coli and HeLa cells.
Introduction
The photobleaching half-time reported for the green chromophore of E2-Red/Green cannot be compared directly to the photobleaching half-times of red chromophores because a different filter set was used e Because TurboRFP showed very poor solubility during extraction from bacteria, we were unable to perform brightness measurements for this protein have also created improved oligomeric red FPs such as DsRed-Express (14), Kusabira-Orange (KO), TurboRFP (6), Katushka (8) , and RFP611, RFP637, and RFP639 (15) . These oligomeric FPs cannot be used as fusion tags, but they are suitable for labeling organelles, whole cells, tissues, and entire organisms. A serious problem with both monomeric and oligomeric FPs is cytotoxicity (16) . Most of the available red FPs show pronounced cytotoxicity that presumably stems from aggregation (17) (18) (19) . For this reason, we modified the surface of DsRedExpress to create a tetrameric derivative that shows minimal higher-order aggregation. The resulting FP, DsRed-Express2, combines low cytotoxicity with favorable photophysical properties such as brightness, fast maturation, photostability, and pH stability (17) . As a result, the tetrameric DsRed-Express2 is an ideal red FP for whole-cell labeling.
Noncytotoxic color variants were then engineered by modifying the interior of DsRed-Express2. This approach yielded three tetrameric derivatives termed E2-Orange (18), E2-Red/ Green (18) , and E2-Crimson (19) . Like the parental DsRedExpress2, these new variants substantially outperform other FPs with regard to cytotoxicity in bacterial and mammalian systems (17) (18) (19) . E2-Orange is ideal for multi-color experiments involving green and far-red FPs (Fig. 1a) , while E2-Red/Green is useful as a "third color" for flow cytometry in combination with red and green FPs (Fig. 1b) . E2-Crimson is particularly noteworthy because it is the fastest-maturing red or far-red FP, the brightest far-red FP, and the only known member of the GFP family that is efficiently excited with standard 633-nm lasers. As a result, E2-Crimson is useful for multi-color microscopy and flow cytometry (Fig. 1c) . The methods used to engineer and evaluate DsRed-Express2 and its derivatives are detailed below, and can be used as a guide for the development of new noncytotoxic FPs.
1. Luria Broth (LB) plates supplemented with 100 g/mL ampicillin.
2. Chemically competent Escherichia coli (E. coli) DH5 cells.
3. Mutagenic library encoded in pQE-60NA (17) , which is a modified version of the pQE-60 vector (Qiagen, Valencia, CA) lacking the hexahistidine tag. pQE-60NA is a low-copy vector that constitutively expresses genes from a mediumstrength T5 promoter flanked by two lac operator sequences. 11. Analysis software such as FlowJo (Tree Star Inc., Ashland, OR).
Materials

293-T/17 cells (CRL-11268; ATCC).
Culture medium (see Subheading 2.4).
3. Lenti-X Expression Kit (Clontech, Mountain View, CA), including the pLVX-Puro plasmid.
4. QuickTiter Lentivirus Quantitation Kit (Cell Biolabs, Inc., San Diego, CA).
The engineering of useful FPs for whole-cell labeling typically involves multiple rounds of mutagenesis. To generate DsRedExpress2, we employed targeted or random mutagenesis followed by screening for improved variants. Each screen was conducted in
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two stages, in which a preliminary selection for bright clones was followed by a bacterial-lysis assay to measure aggregation. This general approach can be used to create noncytotoxic derivatives of FPs that have desirable photophysical properties. Oligomeric FPs are best suited to optimization by this strategy, because the multivalent nature of an oligomeric FP enhances the functional affinity that can be detected using the bacterial lysis assay. In our experience, high solubility of an oligomeric FP in the bacterial-lysis assay correlates strongly with low cytotoxicity in bacterial and mammalian cells. However, cytotoxicity should be measured for each FP. To test for cytotoxicity in bacteria, E. coli colonies expressing a given FP are compared to colonies grown under repressing conditions. Smaller colonies indicate greater cytotoxicity. To test for cytotoxicity in mammalian cells, FPs are expressed in HeLa cells either transiently or by lentiviral transduction, and the fluorescence signal is monitored for several days using flow cytometry. With a cytotoxic FP, the average brightness of the cell population decreases over time, whereas with a noncytotoxic FP, such as enhanced GFP (EGFP) or DsRed-Express2, the average brightness remains steady over time.
1. Transform pQE60-NA-based libraries into DH5 cells using standard protocols. Spread the transformation mixture on LB + ampicillin plates at a density that yields approximately 1,000-1,500 colonies per 100-mm Petri plate.
2. After 12-15 h growth at 37°C (see Note 3), examine colony fluorescence using the slide projector, as follows. In a dark room, place an appropriate bandpass filter over the slide projector light source. Wearing an appropriate emission filter goggles, illuminate the Petri plate with the lid off and look for the brightest colonies. Rotate the Petri plate to assure that all regions are examined.
3. Using sterile toothpicks, pick the brightest colonies (approximately 10% of the total) into 96-well plates for screening in the aggregation assay, or restreak promising colonies for maintenance (see Note 4).
1. Fill each well of a 96-well round-bottom plate with 175 L of LB + ampicillin. As described in Subheading 3.1, pick individual fluorescent E. coli colonies into the wells. In each plate, set aside four control wells for clones expressing the FP that was the template for mutagenesis (see Note 5) . Grow 10-12 h at 37°C (see Note 6), shaking at an angle in an orbital shaker.
2. To store clones for later recovery, use a multichannel pipette to spot 2 L each from 48 wells onto an LB + ampicillin plate in a grid pattern. Label the Petri plates according to well number.
Screening E. coli Colonies for Brightness
Screening for Aggregation Using the Bacterial Lysis Assay
Incubate the Petri plates at 37°C for 12-15 h, and store them at 4°C.
3. Meanwhile, for each 96-well plate, centrifuge the remaining culture samples for 5 min at 3,000 × g. Carefully remove the supernatants using a multichannel pipette.
4. Resuspend each cell pellet in 100 L BPER II using a multichannel pipette. Allow the lysis to proceed for 20 min at 37°C in an orbital shaker.
5. Centrifuge each 96-well plate for 5 min at 3,000 × g. Using a multichannel pipette transfer the supernatants to a pair of black 96-well plates, skipping every other column to leave room for the corresponding pellet fractions. Be careful not to create bubbles during the transfer. 9. For each well, compare the aggregation value to the average aggregation value for the four template wells. Calculate the standard error of the mean (s.e.m.) for the four template wells (see Note 7). Multiply the s.e.m. by two and subtract it from the mean aggregation value for the remaining 92 wells, thereby obtaining a threshold for significance. Any well with an aggregation value less than or equal to the threshold should be considered promising for further analysis.
10. To evaluate promising candidates, restreak from the replica spots (step 2) on fresh LB + ampicillin plates. For each candidate, pick four to eight restreaked colonies into 96-well plates, and repeat the aggregation assay with a template control.
Candidates that are reproducibly more soluble than the template should be characterized further by preparing miniprep DNA for sequencing.
11. After obtaining the sequences of the improved variants, build a combinatorial library that includes the solubility-enhancing mutations as well as the original codons. In some cases, it may be relevant to test additional mutations at key positions (see Note 8).
12. Screen this library as described above (see Note 9) to identify the optimal combination of mutations. For each FP, a bacterial-lysis assay was used to determine the aggregation value, which is defined as the percentage of the total fluorescence signal in the pellet fraction. A high aggregation value indicates the formation of higher-order aggregates. As a reference, EGFP has an aggregation value of only 3%. In these assays, green fluorescence was measured with 470 ± 10 nm excitation and 510 ± 10 nm emission, orange fluorescence with 540 ± 10 nm excitation and 560 ± 10 nm emission, red fluorescence with 560 ± 20 nm excitation and 600 ± 20 nm emission, and far-red fluorescence with 595 ± 20 nm excitation and 640 ± 20 nm emission. KO* is a modified version of KO in which synonymous alternative codons were used near the translation start site to enhance bacterial expression (18) .
under derepressing conditions indicate low cytotoxicity (see Note 11) . An example of the colony size assay is shown in Fig. 3a .
5. Colony size is a meaningful measure only if different FPs are expressed at similar levels (see Note 12) . Expression is analyzed by SDS-PAGE of cell lysates. For this purpose, grow transformed clones overnight at 37°C in 5-mL cultures of LB + ampicillin + kanamycin to generate saturated precultures. Dilute each preculture to an OD 600 of 0.05 in 5 mL of LB + ampicillin + kanamycin in a 50-mL baffled flask. After growth for 2 h at 37°C in an orbital shaker to yield an OD 600 of ~0.5, add 1 mM IPTG to induce FP expression, and incubate with shaking for 4 h at 37°C. Then centrifuge 1 OD 600 unit of each culture in a microfuge tube, resuspend each cell pellet in 200 L of 1× SDS-PAGE sample loading buffer, and repressor plasmid were transformed with pQE-60NA encoding either DsRed-Express2, E2-Red/Green, E2-Orange, mOrange2, KO, or KO* (see Fig. 2 legend) . In this assay, cells expressing DsRed-Express2, E2-Red/Green, and E2-Orange produced large colonies, indicating low cytotoxicity. Cells expressing mOrange2 and KO* produced very small or pinprick colonies, respectively, indicating cytotoxicity. Cells expressing KO produced large colonies, but these colonies were nearly colorless due to poor expression. (b) Quantitation of FP expression under derepressing conditions. Cells were grown to an OD 600 of ~0.6 and then treated with 1 mM IPTG for 4 h. Whole-cell lysates were separated using SDS-PAGE followed by staining with Coomassie Blue. Control cells were transformed with the empty pQE-60NA vector. The image shows that KO expression was very low, while KO* expression was comparable to that of other FPs. 3. Add the cell suspension to a 15-mL conical tube and centrifuge for 5 min at 2,000 × g.
4.
Discard the supernatant, and resuspend the cell pellet in 5 mL of fresh culture medium.
5. Determine the cell density using a hemocytometer. 5. Remove the culture medium and replace it with exactly 2 mL of fresh culture medium per well.
6. Add 1.6 L of 10 mg/mL polybrene to each well for a final concentration of 8 g/mL (see Note 16).
7. Add equivalent titers of viral particles to each well, resulting in three replicates per FP. Incubate for 24 h at 37°C.
8. Remove the culture medium and excess viral particles, wash each well with 2 mL of culture medium, and add 2 mL of fresh culture medium. This time point is defined as day 0.
9. Incubate for 72 h at 37°C to allow expression of the FPs.
Generation of Lentiviral Vectors and HeLa Cell Lentiviral Transduction
Assay for Cytotoxicity 1. E. coli strain DH5 is optimal for use in the bacterial lysis assay. In our experience, other strains do not lyse as efficiently in BPER II.
2. Dissolve all ingredients except -mercaptoethanol in 90% of the total volume. Add fresh -mercaptoethanol immediately before use.
3. Screening colonies as early as possible for brightness allows for selection of mutants that are both bright and rapidly maturing.
4. Restreak promising candidates on adjacent sectors of the same plate to examine relative brightness. As a control, streak bacteria expressing the template FP.
5. Due to slight variability in the procedure, each plate should include clones carrying the template FP for direct comparison with mutants.
6. When expressing extremely cytotoxic FPs, grow cells containing the pREP4 plasmid under repressing conditions and then derepress expression with IPTG. In this case, allow the cells to grow for 3-4 h, add 1 mM IPTG, and continue the incubation for 6-12 h.
7. Calculate s.e.m. by dividing the standard deviation by the square root of the number of samples.
8. In our experience, mutation to charged residues such as lysine can help to increase solubility. These mutations may not be 4. Notes discovered through random mutagenesis by error-prone PCR due to the limited number of codon substitutions that can be obtained from single point mutations.
9. To determine the number of colonies that should be screened in this assay, determine the size of your library by calculating the total number of possible mutant combinations. For example, if two mutations are screened at each of three positions, the library size is 2 3 or eight potential clones. A tenfold overscreening is generally sufficient to identify all of the relevant clones. In the example given above, 80 colonies would be chosen for the bacterial lysis assay. 11. If colonies are not visible to the naked eye, they can sometimes be seen with the slide projector assay as fluorescent "pinprick" colonies.
12. For certain FPs, bacterial expression from the endogenous start codon may be very low, yielding large, nearly colorless colonies under derepressing conditions. This effect is likely due to formation of secondary structure near the 5 end of the mRNA (20, 21) . In such a case, the FP cannot be tested using this assay. However, we have successfully introduced silent mutations within the first few codons of FP genes, thereby increasing bacterial expression and allowing for analysis of cytotoxicity. As an example, the original KO and the expression-enhanced KO* (18) are shown in Fig. 3 .
13. Trypsin-EDTA and all media should be pre-warmed to 37°C before use. This pre-warming is assumed for all steps that describe Trypsin-EDTA treatments, washes in culture medium, and changes of culture medium.
14. Freezing and thawing lentiviral particles may reduce their efficacy. For this reason, aliquots are recommended for storage.
15. This method measures the total titer of the viral particles, and is not a measure of viral particles that are competent for transduction.
16. 4-10 g/mL of polybrene is typically used for lentiviral transduction. Therefore, it is usually unnecessary to add more polybrene to adjust for the change in volume caused by addition of viral particles. However, if the viral particles are very dilute and more than 1 mL of viral particle solution is added, adjust the polybrene concentration to 8 g/mL.
